CIK 0001010086
- Accelerated filer
SIGA TECHNOLOGIES INC
Sign in to watch- Ticker
- SIGA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133864870
- Phone
- +1 212-672-9100
- Business address
- 31 EAST 62ND STREET, NEW YORK, NY, 10065
- Former names
- SIGA PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-22 | ROSE ERIC A MD Director | Option exercise | +100,000 | 1,093,094 | ||
| 2019-11-22 | ROSE ERIC A MD Director | Shares withheld for taxes | −54,501 | $4.92 | $268K | 1,038,593 |
| 2019-11-22 | ROSE ERIC A MD Director | Option exercise · Restricted Stock Units | −100,000 | 0 | ||
| 2019-08-23 | SAVAS PAUL G Director | Purchase | +10,000 | $4.95 | $50K | 272,847 |
| 2019-08-09 | SAVAS PAUL G Director | Purchase | +10,000 | $5.08 | $51K | 262,847 |
| 2019-07-31 | Luckshire Daniel J Executive VP & CFO | Grant or award | +26,666 | 232,731 | ||
| 2019-07-31 | Luckshire Daniel J Executive VP & CFO | Shares withheld for taxes | −12,788 | $5.60 | $72K | 219,943 |
| 2019-07-31 | Luckshire Daniel J Executive VP & CFO | Grant or award · Restricted Stock Units | +53,334 | 53,334 | ||
| 2019-07-31 | Abrams Robin Elizabeth General Counsel and CAO | Grant or award | +26,666 | 34,680 | ||
| 2019-07-31 | Abrams Robin Elizabeth General Counsel and CAO | Shares withheld for taxes | −12,788 | $5.60 | $72K | 21,892 |
| 2019-07-31 | Abrams Robin Elizabeth General Counsel and CAO | Grant or award · Restricted Stock Units | +53,334 | 53,334 | ||
| 2019-06-07 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −16,000 | $5.58 | $89K | 147,465 |
| 2019-06-06 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −17,000 | $5.57 | $95K | 163,645 |
| 2019-06-05 | Antal James Director | Sale | −30,000 | $5.70 | $171K | 130,875 |
| 2019-06-05 | Hruby Dennis E VP & Chief Scientific Officer | Sale | −17,000 | $5.68 | $97K | 180,465 |
| 2019-06-04 | BAYER MICHAEL J Director | Purchase | +12,500 | $5.74 | $72K | 132,244 |
| 2019-05-22 | SAVAS PAUL G Director | Option exercise | +15,000 | 252,847 | ||
| 2019-05-22 | SAVAS PAUL G Director | Option exercise · Restricted Stock Units | −15,000 | 0 | ||
| 2019-05-22 | BAYER MICHAEL J Director | Option exercise | +15,000 | 134,744 | ||
| 2019-05-22 | BAYER MICHAEL J Director | Option exercise · Restricted Stock Units | −15,000 | 0 |
Page 15 of 28 · 558 trades